These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 33970726)

  • 21. Real-world costs of autosomal dominant polycystic kidney disease in the Nordics.
    Eriksson D; Karlsson L; Eklund O; Dieperink H; Honkanen E; Melin J; Selvig K; Lundberg J
    BMC Health Serv Res; 2017 Aug; 17(1):560. PubMed ID: 28806944
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence and renal prognosis of diagnosed autosomal dominant polycystic kidney disease in Japan.
    Higashihara E; Nutahara K; Kojima M; Tamakoshi A; Yoshiyuki O; Sakai H; Kurokawa K
    Nephron; 1998 Dec; 80(4):421-7. PubMed ID: 9832641
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Healthcare Resource Utilization and Costs Associated with Autosomal Dominant Polycystic Kidney Disease.
    Blanchette CM; Iorga ŞR; Altan A; Seare JG; Fan Y; Rossetti S; Gutierrez B
    J Health Econ Outcomes Res; 2014; 2(1):63-74. PubMed ID: 37664083
    [No Abstract]   [Full Text] [Related]  

  • 24. Uroflowmetry alterations in patients with autosomal dominant polycystic kidney disease.
    Lai S; Mittherhofer AP; Cianci R; Riviello L; Vocaturi M; Mastroluca D; Ciccariello M; Von Heland M; Ricciuti GP; Salciccia S; Mazzaferro S
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):2734-2743. PubMed ID: 31002123
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Urinary Angiotensinogen in addition to Imaging Classification in the Prediction of Renal Outcome in Autosomal Dominant Polycystic Kidney Disease.
    Park HC; Kim J; Cho A; Kim DH; Lee YK; Ryu H; Kim H; Oh KH; Oh YK; Hwang YH; Lee KB; Kim SW; Kim YH; Lee J; Ahn C;
    J Korean Med Sci; 2020 Jun; 35(22):e165. PubMed ID: 32508065
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Progression of autosomal dominant kidney disease: measurement of the stage transitions of chronic kidney disease.
    Blanchette CM; Liang C; Lubeck DP; Newsome B; Rossetti S; Gu X; Gutierrez B; Lin ND
    Drugs Context; 2015; 4():212275. PubMed ID: 25922609
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiovascular risk factors and the impact on prognosis in patients with chronic kidney disease secondary to autosomal dominant polycystic kidney disease.
    Gorriz JL; Arroyo D; D'Marco L; Torra R; Tomás P; Puchades MJ; Panizo N; Pantoja J; Montomoli M; Llisterri JL; Pallares-Carratalá V; Valdivielso JM
    BMC Nephrol; 2021 Mar; 22(1):110. PubMed ID: 33765945
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of arginine vasopressin surrogate marker urinary copeptin with severity of autosomal dominant polycystic kidney disease (ADPKD).
    Nakajima A; Lu Y; Kawano H; Horie S; Muto S
    Clin Exp Nephrol; 2015 Dec; 19(6):1199-205. PubMed ID: 25715868
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NOS3 tagSNPs does not modify the chronic kidney disease progression in autosomal dominant polycystic kidney disease.
    Ramanathan G; Periyasamy S; Lakkakula BV
    Nephrology (Carlton); 2014 Sep; 19(9):537-41. PubMed ID: 24824375
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypomagnesaemia is absent in children with autosomal dominant polycystic kidney disease.
    Seeman T; Fořtová M; Sopko B; Průša R; Pohl M; John U
    Ann Clin Biochem; 2019 Jan; 56(1):90-94. PubMed ID: 29874928
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The association of serum angiogenic growth factors with renal structure and function in patients with adult autosomal dominant polycystic kidney disease.
    Coban M; Inci A
    Int Urol Nephrol; 2018 Jul; 50(7):1293-1300. PubMed ID: 29654395
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A model to predict disease progression in patients with autosomal dominant polycystic kidney disease (ADPKD): the ADPKD Outcomes Model.
    McEwan P; Bennett Wilton H; Ong ACM; Ørskov B; Sandford R; Scolari F; Cabrera MV; Walz G; O'Reilly K; Robinson P
    BMC Nephrol; 2018 Feb; 19(1):37. PubMed ID: 29439650
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aldosterone synthase gene is not a major susceptibility gene for progression of chronic kidney disease in patients with autosomal dominant polycystic kidney disease.
    Ramanathan G; Elumalai R; Periyasamy S; Lakkakula BVKS
    Saudi J Kidney Dis Transpl; 2017; 28(3):552-557. PubMed ID: 28540892
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rapid Progression of Autosomal Dominant Polycystic Kidney Disease: Urinary Biomarkers as Predictors.
    Messchendorp AL; Meijer E; Visser FW; Engels GE; Kappert P; Losekoot M; Peters DJM; Gansevoort RT;
    Am J Nephrol; 2019; 50(5):375-385. PubMed ID: 31600749
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors influencing progression of renal failure in autosomal dominant polycystic kidney disease.
    Choukroun G; Itakura Y; Albouze G; Christophe JL; Man NK; Grünfeld JP; Jungers P
    J Am Soc Nephrol; 1995 Dec; 6(6):1634-42. PubMed ID: 8749691
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Medical resource utilization and costs associated with autosomal dominant polycystic kidney disease in the USA: a retrospective matched cohort analysis of private insurer data.
    Knight T; Schaefer C; Krasa H; Oberdhan D; Chapman A; Perrone RD
    Clinicoecon Outcomes Res; 2015; 7():123-32. PubMed ID: 25759590
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of autosomal dominant polycystic kidney disease with cardiovascular disease: a US-National Inpatient Perspective.
    Abou Heidar N; Chehab O; Morsi RZ; Elias J; El Mouhayyar C; Kanj A; Ajam M; Haykal A; Pahuja M; Dakik H; Levine D; Imran N; Abidov A
    Clin Exp Nephrol; 2022 Jul; 26(7):659-668. PubMed ID: 35212882
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trigger Warning: How Modern Diet, Lifestyle, and Environment Pull the Trigger on Autosomal Dominant Polycystic Kidney Disease Progression.
    Messing M; Torres JA; Holznecht N; Weimbs T
    Nutrients; 2024 Sep; 16(19):. PubMed ID: 39408247
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of the ACE gene polymorphism with the progression of autosomal dominant polycystic kidney disease.
    Lee KB; Kim UK; Lee CC
    J Korean Med Sci; 2000 Aug; 15(4):431-5. PubMed ID: 10983692
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictors of rapid disease progression in autosomal dominant polycystic kidney disease.
    Corradi V; Gastaldon F; Caprara C; Giuliani A; Martino F; Ferrari F; Ronco C
    Minerva Med; 2017 Feb; 108(1):43-56. PubMed ID: 27701376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.